Search results for "Skin Neoplasms"

showing 10 items of 282 documents

Uncertainty quantification on a spatial Markov-chain model for the progression of skin cancer

2019

AbstractA spatial Markov-chain model is formulated for the progression of skin cancer. The model is based on the division of the computational domain into nodal points, that can be in a binary state: either in ‘cancer state’ or in ‘non-cancer state’. The model assigns probabilities for the non-reversible transition from ‘non-cancer’ state to the ‘cancer state’ that depend on the states of the neighbouring nodes. The likelihood of transition further depends on the life burden intensity of the UV-rays that the skin is exposed to. The probabilistic nature of the process and the uncertainty in the input data is assessed by the use of Monte Carlo simulations. A good fit between experiments on mi…

65C05Skin NeoplasmsComputer scienceQuantitative Biology::Tissues and OrgansMarkovin ketjut0206 medical engineeringMonte Carlo methodPhysics::Medical PhysicsBinary number02 engineering and technologyArticleihosyöpä03 medical and health sciencesMicemedicineAnimalsHumansComputer SimulationStatistical physicsUncertainty quantification60J20stokastiset prosessit030304 developmental biologyProbability0303 health sciencesMarkov chainApplied MathematicsProbabilistic logicUncertaintyState (functional analysis)medicine.disease020601 biomedical engineeringAgricultural and Biological Sciences (miscellaneous)Markov ChainsCardinal pointModeling and Simulation65C40Disease Progressionmatemaattiset mallitSkin cancerMonte Carlo MethodJournal of Mathematical Biology
researchProduct

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

2018

Blastic Plasmacytoid Dendritic Cell Neoplasm is a rare and aggressive hematological malignancy currently lacking an effective therapy. To possibly identify genetic alterations useful for a new treatment design, we analyzed by whole-exome sequencing fourteen Blastic Plasmacytoid Dendritic Cell Neoplasm patients and the patient-derived CAL-1 cell line. The functional enrichment analysis of mutational data reported the epigenetic regulatory program as the most significantly undermined (P<.0001). In particular, twenty-five epigenetic-modifiers were found mutated (e.g., ASXL1, TET2, SUZ12, ARID1A, PHF2, CHD8); ASXL1 was the most frequently affected (28.6% of cases). To evaluate the impact of …

Acute Myeloid LeukemiaBlastic plasmacytoid dendritic cell neoplasm epigenetic mutationsSkin NeoplasmsAzacitidineDecitabinePlasmacytoid dendritic cellGene mutationBiologyDecitabineBPDCNArticleEpigenesis Genetic03 medical and health sciences0302 clinical medicineHistone methylation5’-Azacytidine; Acute Myeloid Leukemia; BPDCN; Decitabine; WESmedicineHumansEpigeneticsExome sequencingRegulation of gene expressionMyeloproliferative DisordersDendritic CellsGenomicsHematology5 -AzacytidineMyeloid Neoplasms5’-AzacytidineCancer researchWES030215 immunologymedicine.drugHaematologica
researchProduct

Epithelial markers and differentiation in adnexal neoplasms of the skin: an immunohistochemical study including individual cytokeratins

1995

Applying immunohistochemical procedures for the detection of eight different cytokeratin (CK) polypeptides and other differentiation markers, we compared the staining patterns of normal cutaneous structures with those of benign adnexal tumors (n = 65). Syringomas exhibited a marker pattern highly reminiscent of that seen in normal dermal eccrine ducts (EMA in peripheral cells, CK 10 in intermediate cells, and CK 6, CK 19, and CEA in luminal cells). Nodular hidradenomas exhibited complex patterns suggesting relationship between tumor cells, including clear cells, and normal secretory coil cells (CK 7, CK 8, CK 19, and EMA); however, dermal-duct and epidermoid differentiation were also detect…

AdenomaPathologymedicine.medical_specialtySkin NeoplasmsHistologyHidradenomaCellular differentiationDermatologyBiologyBinding CompetitiveInner root sheathPathology and Forensic MedicineCytokeratinReference ValuesBiomarkers TumormedicineCarcinomaHumansNeoplasms Basal CellAdenoma Sweat GlandSyringomaMyoepithelial cellAntibodies MonoclonalCell Differentiationmedicine.diseaseCarcinoma Adenoid CysticImmunohistochemistrySweat GlandsStainingEpidermal CellsKeratinsImmunohistochemistryEpidermisJournal of Cutaneous Pathology
researchProduct

Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Der…

2021

Abstract Aim Immune checkpoint inhibition (ICI) triggers immune-related adverse events (irAEs). The relevance of lipase elevation remains unclear. Patients and methods Skin cancer patients with newly detected serum lipase elevation (at least twofold upper normal limit) or newly diagnosed type I diabetes mellitus upon ICI therapy were retrospectively collected at 14 German skin cancer centres. Results We identified 68 patients with lipase elevation occurring after a median time of 19 (range 1–181) weeks on ICI, 15 (22%) thereof had symptoms consistent with pancreatitis. Forty-seven patients (73%) had other irAE, mainly colitis. Discontinuation (n = 24, 35%) or interruption (n = 26, 38%) of I…

AdultBlood GlucoseMale0301 basic medicineCancer Researchmedicine.medical_specialtySkin NeoplasmsTime FactorsMedizinGastroenterologyThyroiditisYoung Adult03 medical and health sciences0302 clinical medicinePredictive Value of TestsGermanyInternal medicineDiabetes mellitusmedicineHumansLipaseAdverse effectImmune Checkpoint InhibitorsMelanomaAgedRetrospective StudiesAged 80 and overType 1 diabetesbiologybusiness.industryDiabetes; Diabetes mellitus; Immune checkpoint inhibitors; Immune-related adverse events; Ipilimumab; Lipase; Nivolumab; Pancreatitis; PD-1 inhibitor; Pembrolizumab; Adult; Aged; Aged 80 and over; Biomarkers; Blood Glucose; Diabetes Mellitus Type 1; Exocrine Pancreatic Insufficiency; Female; Germany; Humans; Immune Checkpoint Inhibitors; Lipase; Male; Melanoma; Middle Aged; Pancreatitis; Predictive Value of Tests; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Up-Regulation; Young AdultLipaseMiddle Agedmedicine.diseaseUp-RegulationKetoacidosisDiabetes Mellitus Type 1Treatment Outcome030104 developmental biologyPancreatitisOncology030220 oncology & carcinogenesisbiology.proteinPancreatitisExocrine Pancreatic InsufficiencyFemaleSkin cancerbusinessBiomarkersEuropean Journal of Cancer
researchProduct

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients

2006

A significant percentage of stage II melanoma patients (tumor thickness >1 mm) remain at risk of tumor recurrence after primary tumor excision. In this study, we used tumor antigen-pulsed dendritic cells as an adjuvant for immunization of these “high-risk” melanoma patients after resection of the primary tumor. A total of 13 patients were included and vaccinated 6 times every 14 days with autologous dendritic cells pulsed with a MelanA/MART-1 peptide in combination with a recall antigen. Antigen-specific immune responses were monitored before, during and up to 1 year after the last vaccination. The majority of patients exhibited increased recall antigen-specific CD4+ T cell responses upon v…

AdultCD4-Positive T-LymphocytesCancer ResearchSkin NeoplasmsT cellCD8-Positive T-LymphocytesCancer VaccinesMART-1 AntigenImmune systemAdjuvants ImmunologicAntigens NeoplasmHumansMedicineMelanomaCell Proliferationbusiness.industryMelanomaVaccinationDendritic CellsDendritic cellmedicine.diseasePrimary tumorTumor antigenNeoplasm ProteinsTreatment Outcomemedicine.anatomical_structureddc: 610OncologyImmunizationImmunologybusinessCD8International Journal of Cancer
researchProduct

An algorithm for oncologic scalp reconstruction.

2010

Background: Modern reconstructive surgery allows for radical resection and reconstruction of any scalp tumor. However, a significant number of patients are still not treated optimally because of incomplete reconstructive guidelines. Methods: The treatment of scalp tumors was documented in 60 patients over a 10-year period. Data regarding tumor type, size, and localization; reconstructive procedure; oncologic, functional, and aesthetic outcome; and complications were collected and analyzed retrospectively. These data were correlated to recurrence and survival rates. The findings extracted from the data were amalgamated to produce the proposed reconstructive algorithm. Results: Five reconstru…

AdultGraft RejectionMalemedicine.medical_specialtyReconstructive surgerySkin NeoplasmsEstheticsSettore MED/19 - Chirurgia PlasticaRisk AssessmentSkin Cancer Head and Neck CancerSurgical FlapsCohort StudiesYoung AdultScalp reconstructionText miningHumansMedicineTumor typeAgedRetrospective StudiesAged 80 and overWound HealingScalpbusiness.industryGraft SurvivalRetrospective cohort studyPattern recognitionSkin TransplantationMiddle AgedPlastic Surgery ProceduresTissue transferSurgeryPlanning processmedicine.anatomical_structureScalpFemaleSurgeryArtificial intelligenceRadical resectionbusinessAlgorithmAlgorithms
researchProduct

High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma

2016

AimsIt has been proposed that the expression of chemokines and chemokine receptors by melanoma cells may have a role in tumour immune escape. Chemokine CCL27 is reported to be expressed specifically on the epidermal keratinocytes. The implication of CCL27 in cutaneous melanomas is currently unresolved. It has been suggested that CCL27 expression in melanomas can induce antitumoral immunity, and that CCL27 may suppress tumour growth probably due to the local lymphocyte recruitment.MethodsWe studied CCL27 chemokine expression in three different concentric epidermal areas covering the primary cutaneous melanoma in patients with a long clinical follow-up. Our study included 91 cases of primary …

AdultKeratinocytesMale0301 basic medicinePathologymedicine.medical_specialtyChemokineSkin NeoplasmsLymphocyteBiologyDisease-Free SurvivalPathology and Forensic MedicineYoung Adult03 medical and health sciencesChemokine receptor0302 clinical medicinemedicineHumansMelanomaAgedAged 80 and overEpidermis (botany)Chemokine CCL27MelanomaGeneral MedicineMiddle AgedPrognosismedicine.diseaseImmunohistochemistrySurvival Rate030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisCutaneous melanomabiology.proteinImmunohistochemistryFemaleCCL27EpidermisJournal of Clinical Pathology
researchProduct

Dermoscopy of cutaneous smooth muscle neoplasms: a morphological study of 136 cases

2019

BACKGROUND: A variety of cutaneous smooth muscle neoplasms may arise in the skin and are frequently unrecognized by clinicians. There is sparse data relating to the dermoscopy of piloleiomyomas (PL), and nothing has been published about the dermoscopy of angioleiomyomas (AL) and leiomyosarcomas (LS). OBJECTIVES: To evaluate the morphological findings of a large series of cutaneous PL, AL and LS under dermoscopic observation, comparing these findings among them. METHODS: Digital dermoscopic images of 136 histopathologically confirmed cases of cutaneous smooth muscle neoplasms (114 PL, 13 AL and 9 LS) collected from 10 Hospitals in Spain, Austria and Italy were evaluated for the presence of d…

AdultLeiomyosarcomaMaleLeiomyosarcomaPathologymedicine.medical_specialtySkin NeoplasmsAngiomyomaDermoscopyDermoscopy angioleiomyoma leiomyosarcoma piloleiomyoma smooth muscle tumorsDiagnostic accuracyDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSmooth musclemedicineHumansAgedDermoscopy; angioleiomyoma; leiomyosarcoma ; piloleiomyoma; smooth muscle tumorssmooth muscle tumorsbusiness.industryLarge seriesMuscle SmoothleiomyosarcomaMiddle Agedangioleiomyomamedicine.diseaseAngiomyomaInfectious Diseases030220 oncology & carcinogenesisMuscleFemaleSmoothpiloleiomyomaAdult; Aged; Angiomyoma; Female; Humans; Leiomyosarcoma; Male; Middle Aged; Muscle Smooth; Skin Neoplasms; DermoscopybusinessJournal of the European Academy of Dermatology and Venereology
researchProduct

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European Intern…

2020

Electrochemotherapy (ECT) is a treatment for both primary and secondary cutaneous tumours. The international Network for sharing practices on ECT group investigates treatment outcomes after ECT using a common database with defined parameters.Twenty-eight centres across Europe prospectively uploaded data over an 11-year period. Response rates were investigated in relation to primary diagnosis, tumour size, choice of electrode type, route of bleomycin administration, electrical parameters recorded and previous irradiation in the treated field.Nine hundred eighty-seven patients, with 2482 tumour lesions were included in analysis. The overall response (OR) rate was 85% (complete response [CR]: …

AdultMale0301 basic medicineCancer ResearchElectrochemotherapySkin NeoplasmsDatabases FactualElectrochemotherapySubgroup analysiscomputer.software_genreYoung Adult03 medical and health sciences0302 clinical medicineBreast cancerHumansMedicineBasal cell carcinomaProspective StudiesKaposi's sarcomaAgedAged 80 and overDatabasebusiness.industryMelanomaMiddle Agedmedicine.disease030104 developmental biologyOncology030220 oncology & carcinogenesisFemaleSarcomabusinesscomputerProgressive diseaseEuropean Journal of Cancer
researchProduct

MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas

2020

Several studies have focused on identifying microRNAs involved in the pathogenesis of melanoma. However, its association with clinicopathological features has been scarcely addressed. The aim of this study is to identify microRNAs expression profiles related to aggressive clinicopathological and molecular features, and to analyze the association with melanoma survival. A retrospective and observational study was performed in a series of 179 formalin-fixed paraffin embedded primary cutaneous melanomas. First, a screening analysis on a discovery set (n = 22) using miRNA gene chip array (Affymetrix, Santa Clara, California, USA) was performed. Differentially expressed microRNAs were detected e…

AdultMale0301 basic medicineCancer ResearchPoor prognosisSkin NeoplasmsTERT mutationsDermatologyBiologyPathogenesisBreslow Thickness03 medical and health sciences0302 clinical medicinemicroRNAmelanomamedicineHumansMelanomaMitosisSurvival analysisAgedMelanomaMicroRNA Expression ProfileMiddle AgedPrognosismedicine.diseasemicroRNAsMicroRNAs030104 developmental biologyOncology030220 oncology & carcinogenesisCancer researchFemaleprognosisclinicopathological featuresMelanoma Research
researchProduct